Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction

Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Martín Garcia-Gonzalez; Russel J. Reiter

doi:10.1016/j.amjcard.2005.11.033

Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction

Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Martín Garcia-Gonzalez, Russel J. Reiter

Cell Systems & Anatomy

Research output: Contribution to journal › Article

18 Scopus citations

Abstract

We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events.

Original language	English (US)
Pages (from-to)	1162-1164
Number of pages	3
Journal	American Journal of Cardiology
Volume	97
Issue number	8
DOIs	https://doi.org/10.1016/j.amjcard.2005.11.033
State	Published - Apr 15 2006

Fingerprint

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Cite this

Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Garcia-Gonzalez, M., & Reiter, R. J. (2006). Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction. American Journal of Cardiology, 97(8), 1162-1164. https://doi.org/10.1016/j.amjcard.2005.11.033

@article{5790c058c2ef45b98a0699464e2ad1cd,

title = "Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction",

abstract = "We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events.",

author = "Alberto Dominguez-Rodriguez and Pedro Abreu-Gonzalez and Mart{\'i}n Garcia-Gonzalez and Reiter, {Russel J.}",

year = "2006",

month = apr

day = "15",

doi = "10.1016/j.amjcard.2005.11.033",

language = "English (US)",

volume = "97",

pages = "1162--1164",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "8",

}

TY - JOUR

T1 - Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction

AU - Dominguez-Rodriguez, Alberto

AU - Abreu-Gonzalez, Pedro

AU - Garcia-Gonzalez, Martín

AU - Reiter, Russel J.

PY - 2006/4/15

Y1 - 2006/4/15

N2 - We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events.

AB - We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events.

UR - http://www.scopus.com/inward/record.url?scp=33645750415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645750415&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.11.033

DO - 10.1016/j.amjcard.2005.11.033

M3 - Article

C2 - 16616019

AN - SCOPUS:33645750415

VL - 97

SP - 1162

EP - 1164

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8

ER -

Access to Document

10.1016/j.amjcard.2005.11.033